FBI Deputy Director Dan Bongino has revealed a major investigation into alleged criminal coverups during the COVID-19 pandemic. The probe focuses on three distinct areas: the virus's origins, the destruction of federal records, and the manipulation of vaccine approval processes.
According to Just The News, FBI agents in Cleveland, New York, and Baltimore are actively investigating these matters. Bongino made the investigation public last week, stating on social media that Americans "deserve answers" about the COVID coverup.
The investigation gained legal momentum following a court ruling that China concealed COVID-19's origins, along with evidence uncovered by congressional investigations. The FBI's work spans multiple jurisdictions and appears to be moving quickly as agents pursue leads on what may be one of the most consequential investigations in recent history.
The Cleveland field office is leading the most extensive part of the investigation, focusing on whether federal scientists or political leaders intentionally misled Americans about COVID-19's origins.
Evidence emerging from Missouri Attorney General Andrew Bailey's successful $24 billion judgment against China suggests the earliest recorded COVID case in Chinese databases may have been in September 2019. U.S. District Judge Steven N. Limbaugh Jr. wrote in his ruling that "China's pattern of actions strongly suggests that it had knowledge of the existence and human-to-human transmission of the COVID-19 virus as early as September 2019."
FBI agents are investigating when American scientists or federal officials learned about concerns in China and whether they participated in a coverup. One piece of evidence involves a Chinese scientist who attempted to submit data on human-to-human transmission in December 2019, only to have the information removed from a U.S. government database by NIH officials.
The Baltimore field office is examining evidence that federal scientists used private emails to hide discussions about COVID and vaccines from public scrutiny.
Emails obtained during the investigation reportedly show scientists admitting they were attempting to circumvent transparency requirements by using non-government communication channels. This practice potentially violated federal record-keeping laws designed to ensure public access to government decision-making.
The investigation is examining whether these actions constituted illegal conduct, particularly if they were done to prevent Americans from learning about important health information or to shield controversial decisions from oversight during the pandemic response.
New York-based FBI agents are investigating potential political manipulation of the COVID vaccine approval process and subsequent efforts to hide emerging side effects from the public.
This branch of the investigation includes scrutiny of heart inflammation cases in young adults and other adverse reactions that critics claim were downplayed during the vaccine rollout. A whistleblower from one of the vaccine manufacturers is reportedly providing information to investigators.
Senator Ron Johnson, who chairs the Permanent Subcommittee on Investigations, has conducted "significant investigative work" on these issues that FBI agents are now examining. The investigation seeks to determine if federal officials prioritized political considerations over public health transparency.
The sprawling FBI investigation represents one of the most extensive probes into pandemic response decisions by government officials and scientists.
Missouri's legal victory against China for COVID coverup has provided investigators with substantial evidence and legal precedent. Judge Limbaugh's ruling cited specific evidence, including statements from a Chinese professor who accessed a confidential national database containing early COVID fatalities from September 2019, well before China's public acknowledgment.
The investigation also examines U.S. State Department information indicating researchers at the Wuhan Institute of Virology became sick with COVID-19 symptoms in autumn 2019, months before China admitted human-to-human transmission was occurring.
